Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers.

Collaborating with some of the world's largest pharmaceutical and consumer product companies, we have a track record and depth of experience in taking products from concept, through development, to manufacturing and final commercialization. 

Therapeutics

Biotechnology

Medical Devices

Corium

Mark Sirgo

Matthew Hand

Shay Etler

Jill Cafaro

Magdalena C.

Blythe Buchanan (she/her)

Tanya Bloker

Josephine Pedalino

Kevin Ostrander

John Neeley

Jeffrey Gaffey

Gary Cleary

Yi Xu

Charles Oh

The Marketing and Market Access team at Corium drives strategic initiatives to maximize the reach and impact of CNS healthcare therapies. They blend insightful market analytics, creative brand executions, and strategic market access solutions to ensure that novel treatments are accessible to patients, caregivers, and clinicians. The team collaborates across departments and with external partners to promote product awareness, optimize sales efforts, and secure coverage and reimbursement from healthcare payers.

Marketing and Market Access

Leadership Team

Medical and Regulatory Affairs

Marketing and Market Access

About

Team members

Other teams at Corium

Leadership Team

Medical and Regulatory Affairs